Corrections to the Pediatric Opportunistic Infections Guidelines
On December 11, 2013, the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children was updated to eliminate the dosing recommendation for anidulafungin for patients 18 years and older (found in the Candida Infections section and in Table 3: Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children—Summary of Recommendations). Users should reference the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents for information on this patient population.
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - Category: Infectious Diseases Source Type: news
More News: Candida | Children | Department of Health | Health | HIV AIDS | Infectious Diseases | Pediatrics